Financial Services

The AI boom runs on powerful chips that generate immense heat. Discover how the once-overlooked HVAC industry is now a critical infrastructure investment.

As Suunto marks 90 years with a retro-inspired watch, it navigates a fierce market, balancing its legacy of innovation with a new focus on sustainability.

With a fresh capital infusion extending its runway into 2027, GRI Bio pushes ahead with promising clinical data for its IPF and autoimmune disease pipeline.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

A new triple-batch collection honors American history, pushing the boundaries of proof and collectibility for the coveted ultra-premium whiskey brand.

As spring tick season begins, a devastating disease threatens cattle herds. Experts urge early vaccination to prevent massive economic and animal losses.

Italian Exhibition Group unveils its 2025-2030 strategy, targeting massive growth with landmark venue expansions and strategic global acquisitions.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

Award-winning Breckenridge Distillery partners with Romano Beverage, signaling a major push by parent company Tilray Brands into Illinois' key spirits market.

A new study reveals financial firms see big returns from AI but struggle with deployment due to poor data quality and IT complexity, forcing a major rethink.

The global convenience giant is set to unveil its next strategic chapter. Here’s what investors, rivals, and customers can expect from the Circle K owner.

R1 secures 'Best in KLAS' for the 7th straight year. We dive into the AI tech and expert services transforming hospital finances across the U.S.

The Center for the Future of Arizona launches a free, data-driven hub to equip journalists and combat declining public trust in media.

As Aspen Aerogels prepares its Q4 results, investors weigh a challenging 2025 against a booming aerogel market and future EV growth prospects.

Affinia Therapeutics gets the green light for a human trial of AFTX-201, a one-time therapy for a devastating genetic heart disease, BAG3 DCM.

Global security leader Securitas acquires OSINT platform Liferaft, signaling a bold move to fuse digital threat intelligence with physical security services.

As AI reshapes jobs, Skillsoft launches its next-gen Percipio platform to help businesses connect learning to measurable skills and workforce readiness.

Aethlon Medical's upcoming Q3 report puts its finances under a microscope as investors weigh a tight cash runway against progress on its Hemopurifier device.

A new biotech partnership is accelerating development of a once-daily tablet for hypoparathyroidism, a rare disease currently requiring injections.

Aramark has increased its quarterly dividend, a move reflecting strong financials. But what does it say about its strategy in a changing global market?